Pediatrix Medical Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,914	2,013	1,995	1,972	1,911
Revenue Growth (YoY)	-4.92%	0.92%	1.15%	3.18%	10.22%
Cost of Revenue	1,420	1,559	1,573	1,505	1,398
Gross Profit	493.7	454.34	421.57	467.03	513.24
Selling, General & Admin	240.79	238.44	227.54	231.4	263.36
Operating Expenses	262.62	270.66	263.71	267.03	295.5
Operating Income	231.09	183.68	157.85	200	217.74
Interest Expense	-35.97	-40.74	-42.08	-39.7	-68.72
Interest & Investment Income	19.05	5.77	4.34	3.67	13.65
Earnings From Equity Investments	3.63	2.34	2.06	1.72	1.91
EBT Excluding Unusual Items	217.8	151.05	122.17	165.7	164.58
Merger & Restructuring Charges	-22.27	-64.26	-2.22	-27.31	-22.1
Impairment of Goodwill	-	-150.64	-148.31	-	-
Gain (Loss) on Sale of Investments	-	-	-20	-	-
Gain (Loss) on Sale of Assets	20.91	-9.7	-	-	7.28
Asset Writedown	-	-27.79	-	-	-
Other Unusual Items	-	-	-	-57.02	-14.53
Pretax Income	216.43	-101.34	-48.36	81.37	135.23
Income Tax Expense	51.04	-2.27	12.05	18.81	27.24
Earnings From Continuing Operations	165.39	-99.07	-60.41	62.56	107.99
Earnings From Discontinued Operations	-	-	-	3.77	22.95
Net Income to Company	165.39	-99.07	-60.41	66.33	130.94
Minority Interest in Earnings	-	-	-	0	0.03
Net Income	165.39	-99.07	-60.41	66.34	130.96
Net Income to Common	165.39	-99.07	-60.41	66.34	130.96
Net Income Growth	-	-	-	-49.35%	-
Shares Outstanding (Basic)	84	83	82	83	85
Shares Outstanding (Diluted)	85	83	82	84	86
Shares Change (YoY)	2.33%	1.37%	-2.28%	-1.99%	2.92%
EPS (Basic)	1.97	-1.19	-0.73	0.79	1.54
EPS (Diluted)	1.94	-1.19	-0.73	0.78	1.53
EPS Growth	-	-	-	-48.62%	-
Free Cash Flow	252.63	184.55	104	137.23	44.49
Free Cash Flow Per Share	2.96	2.21	1.26	1.63	0.52
Gross Margin	25.80%	22.57%	21.14%	23.68%	26.86%
Operating Margin	12.07%	9.13%	7.91%	10.14%	11.39%
Profit Margin	8.64%	-4.92%	-3.03%	3.36%	6.85%
Free Cash Flow Margin	13.20%	9.17%	5.21%	6.96%	2.33%
EBITDA	252.91	215.91	194.02	235.64	249.89
EBITDA Margin	13.21%	10.73%	9.73%	11.95%	13.08%
D&A For EBITDA	21.83	32.23	36.17	35.64	32.15
EBIT	231.09	183.68	157.85	200	217.74
EBIT Margin	12.07%	9.13%	7.91%	10.14%	11.39%
Effective Tax Rate	23.58%	-	-	23.11%	20.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.